Early-life viral infection and allergen exposure interact to induce an asthmatic phenotype in mice

Respiratory Research

Volumn 11, Issue , 2010, Pages

  Siegle, Jessica S ^a   Hansbro, Nicole ^b,c   Herbert, Cristan ^a   Rosenberg, Helene F ^d   Domachowske, Joseph B ^e   Asquith, Kelly L ^b,c   Foster, Paul S ^b,c   Kumar, Rakesh K ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 13; INTERLEUKIN 25; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR ALPHA; INTERLEUKIN 5; OVALBUMIN;

AIRWAY CONSTRICTION; AIRWAY HYPERRESPONSIVENESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BLOOD LEVEL; CONTROLLED STUDY; CONVALESCENCE; DISEASE EXACERBATION; DRUG SENSITIZATION; EMBRYO; EOSINOPHIL; EXPOSURE; FEMALE; HISTOPATHOLOGY; IMMUNE RESPONSE; LUNG LAVAGE; LYMPHOCYTE; MACROPHAGE; MORPHOMETRICS; MOUSE; NEUTROPHIL; NEWBORN INFECTION; NONHUMAN; PHENOTYPE; PNEUMONIA; PROTEIN EXPRESSION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS INFECTION; ANIMAL; BAGG ALBINO MOUSE; NEWBORN; PATHOPHYSIOLOGY; PHYSIOLOGY; RESPIRATORY SYNCYTIAL VIRUS INFECTION; VIROLOGY;

ALLERGENS; ANIMALS; ANIMALS, NEWBORN; ASTHMA; MICE; MICE, INBRED BALB C; PHENOTYPE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES;

EID: 77952466867     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-11-14     Document Type: Article

References (52)

1. Wong GW, Chow CM. Childhood asthma epidemiology: insights from comparative studies of rural and urban populations. Pediatr Pulmonol 2008, 43(2):107-116. 10.1002/ppul.20755, 18092349.
2. Garn H, Renz H. Epidemiological and immunological evidence for the hygiene hypothesis. Immunobiology 2007, 212:441-452. 10.1016/j.imbio.2007.03.006, 17544829.
3. Holt PG, Sly PD. Interactions between RSV infection, asthma, and atopy: unraveling the complexities. J Exp Med 2002, 196(10):1271-1275. 10.1084/jem.20021572, 2193993, 12438419.
4. Holt PG, Sly PD. Prevention of allergic respiratory disease in infants: current aspects and future perspectives. Curr Opin Allergy Clin Immunol 2007, 7(6):547-555. 10.1097/ACI.0b013e3282f14a17, 17989533.
5. Jackson DJ, Gangnon RE, Evans MD, Roberg KA, Anderson EL, Pappas TE, Printz MC, Lee WM, Shult PA, Reisdorf E. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med 2008, 178(7):667-672. 10.1164/rccm.200802-309OC, 2556448, 18565953.
6. Kusel MM, de Klerk NH, Kebadze T, Vohma V, Holt PG, Johnston SL, Sly PD. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol 2007, 119(5):1105-1110. 10.1016/j.jaci.2006.12.669, 17353039.
7. Lemanske RF. Viral infections and asthma inception. J Allergy Clin Immunol 2004, 114:1023-1026. 10.1016/j.jaci.2004.08.031, 15536404.
8. Sigurs N, Gustafsson PM, Bjarnason R, Lundberg F, Schmidt S, Sigurbergsson F, Kjellman B. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med 2005, 171:137-141. 10.1164/rccm.200406-730OC, 15516534.
9. Kristjansson S, Bjarnarson SP, Wennergren G, Palsdottir AH, Arnadottir T, Haraldsson A, Jonsdottir I. Respiratory syncytial virus and other respiratory viruses during the first 3 months of life promote a local TH2-like response. J Allergy Clin Immunol 2005, 116(4):805-811. 10.1016/j.jaci.2005.07.012, 16210054.
10. Simoes EA. Respiratory syncytial virus infection. Lancet 1999, 354(9181):847-852. 10.1016/S0140-6736(99)80040-3, 10485741.
11. Domachowske JB, Bonville CA, Rosenberg HF, et al. Animal models for studying respiratory syncytial virus infection and its long term effects on lung function. Pediatr Infect Dis J 2004, 23:S228-S234. 10.1097/01.inf.0000144672.81955.a4, 15577578.
12. Mohapatra SS, Boyapalle S. Epidemiologic, experimental, and clinical links between respiratory syncytial virus infection and asthma. Clin Microbiol Rev 2008, 21(3):495-504. 10.1128/CMR.00054-07, 2493089, 18625684.
13. Rosenberg HF, Bonville CA, Easton AJ, Domachowske JB. The pneumonia virus of mice infection model for severe respiratory syncytial virus infection: identifying novel targets for therapeutic intervention. Pharmacol Ther 2005, 105(1):1-6. 10.1016/j.pharmthera.2004.09.001, 15626452.
14. Rosenberg HF, Domachowske JB. Pneumonia virus of mice: severe respiratory infection in a natural host. Immunol Lett 2008, 118(1):6-12. 10.1016/j.imlet.2008.03.013, 2494858, 18471897.
15. Bonville CA, Bennett NJ, Koehnlein M, Haines DM, Ellis JA, DelVecchio AM, Rosenberg HF, Domachowske JB. Respiratory dysfunction and proinflammatory chemokines in the pneumonia virus of mice (PVM) model of viral bronchiolitis. Virology 2006, 349(1):87-95. 10.1016/j.virol.2006.02.017, 16563455.
16. Bonville CA, Percopo CM, Dyer KD, Gao J, Prussin C, Foster B, Rosenberg HF, Domachowske JB. Interferon-gamma coordinates CCL3-mediated neutrophil recruitment in vivo. BMC Immunol 2009, 10:14. 10.1186/1471-2172-10-14, 2662797, 19298652.
17. Temelkovski J, Hogan SP, Shepherd DP, Foster PS, Kumar RK. An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax 1998, 53:849-856. 10.1136/thx.53.10.849, 1745083, 10193371.
18. Siegle JS, Hansbro N, Herbert C, Yang M, Foster PS, Kumar RK. Airway hyperreactivity in exacerbation of chronic asthma is independent of eosinophilic inflammation. Am J Respir Cell Mol Biol 2006, 35:565-570. 10.1165/rcmb.2006-0135OC, 16794258.
19. Noben-Trauth N, Shultz LD, Brombacher F, Urban JF, Gu H, Paul WE. An interleukin 4 (IL-4)-independent pathway for CD4+ T cell IL-4 production is revealed in IL-4 receptor-deficient mice. Proc Natl Acad Sci USA 1997, 94(20):10838-10843. 10.1073/pnas.94.20.10838, 23501, 9380721.
20. Weil SC, Hrisinko MA. A hybrid eosinophilic-basophilic granulocyte in chronic granulocytic leukemia. Am J Clin Pathol 1987, 87(1):66-70.
21. Zucker-Franklin D, Grusky G. The identification of eosinophil colonies in soft-agar cultures by differential staining for peroxidase. J Histochem Cytochem 1976, 24(12):1270-1272.
22. Ameredes BT. Cardiac activity during airway resistance alterations with intravenous and inhaled methacholine. Respir Physiol Neurobiol 2004, 139:281-292. 10.1016/j.resp.2003.10.010, 15122994.
23. Asquith KL, Ramshaw HS, Hansbro PM, Beagley KW, Lopez AF, Foster PS. The IL-3/IL-5/GM-CSF common receptor plays a pivotal role in the regulation of Th2 immunity and allergic airway inflammation. J Immunol 2008, 180(2):1199-1206.
24. Ellis JA, Martin BV, Waldner C, Dyer KD, Domachowske JB, Rosenberg HF. Mucosal inoculation with an attenuated mouse pneumovirus strain protects against virulent challenge in wild type and interferon-gamma receptor deficient mice. Vaccine 2007, 25(6):1085-1095. 10.1016/j.vaccine.2006.09.081, 1922442, 17052820.
25. Garvey TL, Dyer KD, Ellis JA, Bonville CA, Foster B, Prussin C, Easton AJ, Domachowske JB, Rosenberg HF. Inflammatory responses to pneumovirus infection in IFN-alpha beta R gene-deleted mice. J Immunol 2005, 175(7):4735-4744.
26. Yi X, Feng F, Xiang Z, Ge L. The effects of allitridin on the expression of transcription factors T-bet and GATA-3 in mice infected by murine cytomegalovirus. J Med Food 2005, 8(3):332-336. 10.1089/jmf.2005.8.332, 16176143.
27. Moyron-Quiroz JE, Rangel-Moreno J, Kusser K, Hartson L, Sprague F, Goodrich S, Woodland DL, Lund FE, Randall TD. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat Med 2004, 10(9):927-934. 10.1038/nm1091, 15311275.
28. Purkerson J, Isakson P. A two-signal model for regulation of immunoglobulin isotype switching. FASEB J 1992, 6(14):3245-3252.
29. Hansbro NG, Horvat JC, Wark PA, Hansbro PM. Understanding the mechanisms of viral induced asthma: New therapeutic directions. Pharmacol Ther 2008, 117(3):313-353. 10.1016/j.pharmthera.2007.11.002, 18234348.
30. Rosenberg HF, Domachowske JB. Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens. 2001, 70:691-698.
31. Barends M, de Rond LG, Dormans J, van Oosten M, Boelen A, Neijens HJ, Osterhaus AD, Kimman TG. Respiratory syncytial virus, pneumonia virus of mice, and influenza A virus differently affect respiratory allergy in mice. Clin Exp Allergy 2004, 34:488-496. 10.1111/j.1365-2222.2004.01906.x, 15005745.
32. Holtzman MJ, Tyner JW, Kim EY, Lo MS, Patel AC, Shornick LP, Agapov E, Zhang Y. Acute and chronic airway responses to viral infection: implications for asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005, 2(2):132-140. 10.1513/pats.200502-015AW, 2713316, 16113481.
33. Culley FJ, Pollott J, Openshaw PJ. Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood. J Exp Med 2002, 196(10):1381-1386. 10.1084/jem.20020943, 2193991, 12438429.
34. Dakhama A, Park JW, Taube C, Joetham A, Balhorn A, Miyahara N, Takeda K, Gelfand EW. The enhancement or prevention of airway hyperresponsiveness during reinfection with respiratory syncytial virus is critically dependent on the age at first infection and IL-13 production. J Immunol 2005, 175:1876-1883.
35. Herbert C, Hettiaratchi A, Webb DC, Thomas PS, Foster PS, Kumar RK. Suppression of cytokine expression by roflumilast and dexamethasone in a model of chronic asthma. Clin Exp Allergy 2008, 38(5):847-856. 10.1111/j.1365-2222.2008.02950.x, 18307529.
36. Laprise C, Laviolette M, Boutet M, Boulet LP. Asymptomatic airway hyperresponsiveness: relationships with airway inflammation and remodelling. Eur RespirJ 1999, 14:63-73.
37. Fedorov IA, Wilson SJ, Davies DE, Holgate ST. Epithelial stress and structural remodelling in childhood asthma. Thorax 2005, 60(5):389-394. 10.1136/thx.2004.030262, 1758889, 15860714.
38. Pohunek P, Warner JO, Turzikova J, Kudrmann J, Roche WR. Markers of eosinophilic inflammation and tissue re-modelling in children before clinically diagnosed bronchial asthma. Pediatr Allergy Immunol 2005, 16(1):43-51. 10.1111/j.1399-3038.2005.00239.x, 15693911.
39. Barbato A, Turato G, Baraldo S, Bazzan E, Calabrese F, Panizzolo C, Zanin ME, Zuin R, Maestrelli P, Fabbri LM, et al. Epithelial damage and angiogenesis in the airways of children with asthma. Am J Respir Crit Care Med 2006, 174:975-981. 10.1164/rccm.200602-189OC, 16917118.
40. Saglani S, Payne DN, Zhu J, Wang Z, Nicholson AG, Bush A, Jeffery PK. Early detection of airway wall remodeling and eosinophilic inflammation in preschool wheezers. Am J Respir Crit Care Med 2007, 176(9):858-864. 10.1164/rccm.200702-212OC, 17702968.
41. Hopp RJ, Townley RG, Biven RE, Bewtra AK, Nair NM. The presence of airway reactivity before the development of asthma. Am Rev Respir Dis 1990, 141(1):2-8.
42. Nakanishi A, Morita S, Iwashita H, Sagiya Y, Ashida Y, Shirafuji H, Fujisawa Y, Nishimura O, Fujino M. Role of gob-5 in mucus overproduction and airway hyperresponsiveness in asthma. Proc Natl Acad Sci USA 2001, 98:5175-5180. 10.1073/pnas.081510898, 33183, 11296262.
43. Long AJ, Sypek JP, Askew R, Fish SC, Mason LE, Williams CM, Goldman SJ. Gob-5 contributes to goblet cell hyperplasia and modulates pulmonary tissue inflammation. Am J Respir Cell Mol Biol 2006, 35:357-365. 10.1165/rcmb.2005-0451OC, 16645179.
44. Collins RA, Gualano RC, Zosky GR, Chiappetta CL, Turner DJ, Colasurdo GN, Hantos Z, Sly PD. Lack of long-term effects of respiratory syncytial virus infection on airway function in mice. Respir Physiol Neurobiol 2007, 156:345-352. 10.1016/j.resp.2006.11.009, 17236822.
45. Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet 2008, 372(9643):1107-1119. 10.1016/S0140-6736(08)61452-X, 18805339.
46. Wenzel S, Wilbraham D, Fuller R, Getz EB, Longphre M. Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies. Lancet 2007, 370(9596):1422-1431. 10.1016/S0140-6736(07)61600-6, 17950857.
47. Gerhold K, Bluemchen K, Franke A, Stock P, Hamelmann E. Exposure to endotoxin and allergen in early life and its effect on allergen sensitization in mice. J Allergy Clin Immunol 2003, 112:389-396. 10.1067/mai.2003.1646, 12897747.
48. Wang Y, McCusker C. Neonatal exposure with LPS and/or allergen prevents experimental allergic airways disease: development of tolerance using environmental antigens. J Allergy Clin Immunol 2006, 118:143-151. 10.1016/j.jaci.2006.03.020, 16815150.
49. Angkasekwinai P, Park H, Wang YH, Wang YH, Chang SH, Corry DB, Liu YJ, Zhu Z, Dong C. Interleukin 25 promotes the initiation of proallergic type 2 responses. J Exp Med 2007, 204:1509-1517. 10.1084/jem.20061675, 2118650, 17562814.
50. Lloyd CM. Dust mites' dirty dealings in the lung. Nat Med 2009, 15:366-367. 10.1038/nm0409-366, 19350005.
51. Lambrecht BN, Hammad H. Biology of lung dendritic cells at the origin of asthma. Immunity 2009, 31:412-424. 10.1016/j.immuni.2009.08.008, 19766084.
52. Sharkhuu T, Matthaei KI, Forbes E, Mahalingam S, Hogan SP, Hansbro PM, Foster PS. Mechanism of interleukin-25 (IL-17E)-induced pulmonary inflammation and airways hyper-reactivity. Clin Exp Allergy 2006, 36:1575-1583. 10.1111/j.1365-2222.2006.02595.x, 17177681.